AnaptysBio, Inc. Forecast, price target & analysts
AnaptysBio, Inc. Target price 2025 - Analyst rating & recommendation
AnaptysBio, Inc. Classifications & Recommendation:
AnaptysBio, Inc. Price Target
| Target Price | $37.82 |
| Price | $21.10 |
| Potential |
79.23%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target AnaptysBio, Inc. 2026 .
The average AnaptysBio, Inc. target price is $37.82.
This is
79.23%
register free of charge
$57.00
170.14%
register free of charge
$18.00
14.69%
register free of charge
|
|
| A rating was issued by 12 analysts: 9 Analysts recommend AnaptysBio, Inc. to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the AnaptysBio, Inc. stock has an average upside potential 2026 of
79.23%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 91.28 | 67.76 |
| 431.93% | 25.77% | |
| EBITDA Margin | -125.26% | -170.70% |
| 86.26% | 38.44% | |
| Net Margin | -170.46% | -232.15% |
| 84.17% | 36.19% |
11 Analysts have issued a sales forecast AnaptysBio, Inc. 2025 . The average AnaptysBio, Inc. sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an AnaptysBio, Inc. EBITDA forecast 2025. The average AnaptysBio, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 AnaptysBio, Inc. Analysts have issued a net profit forecast 2025. The average AnaptysBio, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -5.12 | -5.18 |
| 15.79% | 1.17% | |
| P/E | negative | |
| EV/Sales | 9.24 |
11 Analysts have issued a AnaptysBio, Inc. forecast for earnings per share. The average AnaptysBio, Inc. EPS is
This results in the following potential growth metrics and future valuations:
AnaptysBio, Inc....
Current AnaptysBio, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Guggenheim |
Locked
➜
Locked
|
Locked | May 06 2025 |
| Wedbush |
Locked
➜
Locked
|
Locked | May 01 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Mar 05 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 04 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
| Wedbush |
Locked
➜
Locked
|
Locked | Feb 07 2025 |
| Wolfe Research |
Locked
➜
Locked
|
Locked | Feb 04 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Guggenheim:
Locked
➜
Locked
|
May 06 2025 |
|
Locked
Wedbush:
Locked
➜
Locked
|
May 01 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Mar 05 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 04 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Feb 13 2025 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Feb 07 2025 |
|
Locked
Wolfe Research:
Locked
➜
Locked
|
Feb 04 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
